EECC Cardiology Exam Prep: 2025 MCQs & Board Questions

Decode cardiac conduction disorders with comprehensive coverage of AV blocks (1st, 2nd Mobitz, 3rd degree) and sick sinus syndrome.

Interactive quiz format with detailed ECG examples and clinical correlations.

Essential for EECC preparation with real-world diagnostic scenarios.

Build strong ECG interpretation foundations with essential concepts and systematic approach to electrocardiography.

Engage with interactive quiz format testing rhythm recognition, axis deviation, and waveform analysis.

Strategic preparation for European exam ECG questions.

Master advanced echocardiography techniques including chamber quantification, valvular assessment, and hemodynamic calculations.

Comprehensive quiz-based learning with detailed explanations and clinical applications.

Perfect for European exam candidates seeking imaging excellence.

Sharpen visual interpretation skills with real echocardiographic images testing pathology recognition and measurement accuracy.

Enhance diagnostic confidence through systematic image analysis and pattern recognition.

Essential practice for EECC exam visual assessment questions.

Develop expertise in cardiac catheterization data interpretation including pressure gradients, oxygen saturations, and hemodynamic calculations.

Interactive quiz with detailed answer explanations and clinical reasoning.

Crucial preparation for European exam invasive cardiology questions.

Learn advanced right ventricular function assessment in cardiac tamponade using echocardiographic parameters.

Critical diagnostic skills for emergency and acute care scenarios.

Vital knowledge for European exam emergency cardiology section.

Comprehensive understanding of cardiac tamponade pathophysiology, clinical presentation, and emergency management strategies.

Master diagnostic criteria including Beck's triad and echocardiographic findings.

Crucial for European exam emergency cardiovascular scenarios.

Advanced electrophysiology study techniques including differential pacing protocols and diagnostic maneuvers for arrhythmia localization.

Learn complex EP concepts with clinical applications and interpretation strategies.

Essential for European exam advanced cardiac electrophysiology questions.

Cardiology Case Studies and Diagnoses - presents a series of case studies and diagnostic questions encountered in  cardiology. Each entry typically includes a clinical scenario, imaging or physiological data like echocardiogram findings, ECG results, catheterization pressures and saturations, or chest X-ray descriptions. The questions prompt the reader to identify diagnoses, relevant views or structures, potential differential diagnoses, ECG findings associated with specific conditions, and expected physiological or radiographic features. Conditions range from congenital heart defects like interrupted aortic arch and transposition of the great vessels to acquired conditions and specific findings like a supramitral ring or ruptured sinus of Valsalva. The overarching purpose is likely educational, testing knowledge of various cardiac anomalies and their diagnostic workup in newborns, infants, and children. The lecture primarily focusing on cardiovascular anomalies identified through chest X-rays and in one instance, a CT scan. Each case describes a young patient with specific clinical symptoms, followed by radiographic findings indicative of congenital heart defects. Conditions such as transposition of the great vessels, corrected transposition, tricuspid atresia, Ebstein's anomaly, total anomalous pulmonary venous connection, Scimitar syndrome, and a vascular ring are illustrated. The descriptions highlight key radiological features like cardiomegaly, altered pulmonary vascular markings, and characteristic structural abnormalities. These notes serve as a visual and diagnostic guide for recognizing different congenital cardiac conditions in children.

Comprehensive theoretical foundation in congenital heart disease covering anatomical defects, pathophysiology, and classification systems.

Detailed exploration of common and complex CHD including septal defects, conotruncal anomalies, and cyanotic heart disease.

Essential knowledge for European exam congenital cardiology questions with clinical correlation.

Comprehensive cardiac resynchronization therapy overview including patient selection criteria, device types, and evidence-based indications.

Understand CRT benefits for heart failure management and optimization strategies.

Essential device therapy knowledge for European cardiology exam.

Learn acute coronary syndrome classification with ECG-based localization of STEMI and NSTEMI presentations.

Comprehensive coverage of anterior, inferior, lateral, and posterior MI patterns.

Critical diagnostic skills for European exam ACS management questions.

Advanced implantable cardioverter-defibrillator management covering device programming, therapy optimization, and systematic troubleshooting approaches.

Expert guidance on ICD indications, lead configurations, shock therapy settings, and response to device alerts.

Critical knowledge for European exam device therapy questions with practical clinical applications.

In-depth echocardiography training combining quiz-based learning with fundamental imaging principles and interpretation techniques.

Comprehensive coverage of echo modalities, views, measurements, and pathology identification through interactive questioning.

Strategic preparation for European exam echocardiography sections with evidence-based practice.

Comprehensive exercise stress test methodology covering indications, contraindications, protocols, and interpretation of treadmill testing.

Detailed exploration of ETT procedures, hemodynamic responses, ECG changes, and diagnostic criteria for ischemia detection.

Essential functional assessment knowledge for European exam cardiovascular evaluation questions.

Evolution and clinical application of SGLT2 inhibitors from diabetes management to heart failure therapy with comprehensive mechanistic insights.

Detailed review of landmark trials, cardiovascular benefits, renal protection, and guideline recommendations for SGLT2i use.

Critical pharmacotherapy knowledge for European exam heart failure management questions.

Practical algorithmic approach to prescribing novel lipid-lowering therapies including PCSK9 inhibitors, ezetimibe, and bempedoic acid.

Systematic guidance on patient selection, treatment escalation, and combination therapy strategies for optimal LDL reduction.

Essential dyslipidemia management knowledge for European exam cardiovascular prevention questions.

Comprehensive overview of valvular heart disease pathophysiology, clinical manifestations, diagnostic evaluation, and treatment strategies.

Detailed coverage of stenotic and regurgitant lesions across all valves with timing and indications for intervention.

Essential structural heart disease knowledge for European exam valvular pathology questions.

Timestamp, Slide Content Summary

• 00:00 - 01:05,Title and Introduction: Overview of NICE NG238 and AAC Lipid Pathways; speaker bio for Prof. Narendra Kumar.

• 01:06 - 01:32,"Session Objectives: Risk Assessment, Treatment Optimization (Statins/Newer Agents), and Lifestyle Adherence."

• 01:33 - 03:15,Evidence-Based Remission: Concepts of reversing chronic conditions like T2D through intensive lifestyle/medical intervention.

• 03:16 - 05:01,The Twin Cycle Hypothesis: How liver/pancreatic fat drives metabolic disease and the global health economic context of lipid drugs.

• 05:02 - 07:45,QRISK3 and Non-Fasting Lipids: The shift toward non-fasting blood tests and the specific limitations/underestimations of QRISK3.

• 07:46 - 10:12,"High-Risk Special Groups: Identifying patients (T1D, CKD, Clinical CVD) who bypass QRISK scoring for immediate treatment." 10:13 - 12:30,"Life-Course Risk: The ""Area Under the Curve"" concept—cumulative LDL exposure over decades vs. late-life intervention."

• 12:31 - 15:55,"Familial Hypercholesterolaemia (FH): Identifying FH (TC 7.5, LDL 4.9) and the importance of Simon Broome criteria and cascade testing." 15:56 - 18:20,First-Line Statin Therapy: Dosing standards (Atorvastatin 20mg for Primary vs. 80mg for Secondary Prevention).

• 18:21 - 21:10,"Baseline Diagnostics: Essential pre-treatment checks: Lipid profile, ALT/AST, eGFR, HbA1c, and CK (if symptomatic)."

• 21:11 - 25:00,The 40% Non-HDL Goal: Using Non-HDL as the primary metric for success and the logic behind the 3-month follow-up.

• 25:01 - 28:30,"Statin Intolerance Management: Addressing the Nocebo effect; protocols for ""Statin Challenges"" and switching to Rosuvastatin."

• 28:31 - 32:15,Ezetimibe (Second-Line): Mechanism of blocking gut absorption and achieving an additional 15-20% LDL reduction.

• 32:16 - 36:50,Bempedoic Acid (Nilemdo): A pro-drug activated in the liver to avoid muscle symptoms (SAMS) for intolerant patients. 36:51 - 42:29,"The AAC Escalation Hierarchy: Flowchart of adding Ezetimibe, Bempedoic Acid, and then moving to injectable therapies."

  
  

• 42:30 - 49:20,"Inclisiran (siRNA) Overview: The ""twice-yearly"" injection mechanism and the logistics of nurse-led community administration."

• 49:21 - 53:45,NICE TA733 Eligibility: Criteria for Inclisiran: Secondary prevention patients with persistent LDL 2.6 mmol/L or higher.

• 53:46 - 57:10,PCSK9 Inhibitor MABs: Review of Alirocumab/Evolocumab for very high-risk and FH populations.

• 57:11 - 61:30,The Legacy Effect: Data on the 22% reduction in vascular events per 1 mmol/L LDL drop.

• 61:31 - 65:00,Safety and Side Effects: Managing injection site reactions and confirming lack of liver/muscle toxicity for new agents.

• 65:01 - 72:15,"Addressing Clinical Inertia: The necessity of rapid combination therapy rather than ""wait and see"" monitoring."

• 72:16 - 78:40,"Q&A Session: Discussion on practical implementation in primary care, funding, and the ""primary care playbook"" checklist."

• 78:41 - 81:16,Summary and Closing: Final takeaways on bridging the gap between guidelines and patient adherence. Join this channel to get access to perks:

Comprehensive EECC preparation textbook featuring over 700 multiple-choice questions with detailed explanations and clinical correlations.

Extensive question bank covering all core cardiology topics with updated 2025 edition content and evidence-based answers.

Essential supplementary material for comprehensive European exam preparation and knowledge reinforcement.

Landmark Cardiovascular Clinical Trials part 1 extensively summarizes numerous landmark clinical trials that have shaped the understanding and treatment of various cardiovascular conditions.

It covers pivotal studies concerning heart failure therapies like ARNI, beta-blockers, and SGLT2 inhibitors, as well as interventions for coronary artery disease, including PCI guidance via FFR, culprit versus multivessel PCI strategies, and PCI versus CABG for left main disease.

Furthermore, the document details key trials involving cardiogenic shock management with IABP and Impella,  ultimately illustrating how these trials have influenced current guideline recommendations in cardiology.

❤️ Landmark Cardiovascular Clinical Trials: Hypertension to Dyslipidemia summarizes numerous landmark clinical trials that have significantly shaped the understanding and treatment of various cardiovascular and metabolic conditions. The trials primarily focus on hypertension, myocardial infarction (STEMI), hypertrophic cardiomyopathy, peripheral arterial disease, diabetes, atrial fibrillation, coronary artery disease, dyslipidemia, and pulmonary hypertension. Each summary typically outlines the trial's objective, key outcomes, and resulting clinical impact, often leading to changes in treatment guidelines. Together, these summaries provide a broad overview of the evidence-based foundations guiding modern cardiology and related fields.

Updated 2025 acute coronary syndrome management guidelines covering diagnostic criteria, risk stratification, and evidence-based therapeutic strategies.

Comprehensive review of contemporary ACS care including antiplatelet therapy, revascularization timing, and post-MI management protocols.

Essential current guideline knowledge for European exam ACS questions with latest recommendations.

Pregnancy and Heart Disease Considerations discuss the complex interplay between pregnancy and heart disease, highlighting the increased risks for women with pre-existing cardiovascular conditions due to significant hemodynamic and hormonal changes. It cover the physiological adaptations of the cardiovascular system during different stages of pregnancy, labor, and postpartum, noting how these changes can unmask or worsen heart issues. The sources also detail various cardiac conditions and their management during pregnancy, including valvular diseases, cardiomyopathies like peripartum cardiomyopathy, congenital heart defects, and complications like hypertension and pulmonary hypertension. Furthermore, they address risk stratification tools, the safety of cardiovascular medications, the use of assisted reproductive technologies, and the importance of a multidisciplinary cardio-obstetrics team for optimal maternal and fetal outcomes.

?Cardiomyopathies: Types, Diagnosis, and Treatment

?The provided sources offer a comprehensive overview of several cardiomyopathies, beginning with Dilated Cardiomyopathy (DCM), explaining its characteristics, causes (including genetic factors), diagnostic methods like echocardiography and CMR, and treatment approaches.

?It then transitions to Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), detailing its stages, characteristic electrocardiographic findings, and genetic underpinnings involving desmosomal proteins.

?The discussion broadens to include Takotsubo cardiomyopathy (TC), often stress-induced and reversible, and Tachycardia-induced cardiomyopathy, a reversible condition linked to prolonged rapid heart rates.

?Finally, Peripartum cardiomyopathy (PPCM), occurring during or after pregnancy, and Alcoholic Cardiomyopathy, caused by excessive alcohol consumption, are described, emphasizing their clinical presentations, risk factors, and management, often noting their shared features with general heart failure treatments and the importance of genetic evaluation and counseling across various cardiomyopathy types.